Expression of Cyclooxygenase 2 Is an Independent Prognostic Factor in Human Ovarian Carcinoma
- 31 March 2002
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 160 (3), 893-903
- https://doi.org/10.1016/s0002-9440(10)64912-7
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Expression of Cyclooxygenase-2 in Human Transitional Cell Carcinoma of the Urinary BladderThe American Journal of Pathology, 2001
- p53 And related proteins in epithelial ovarian cancerEuropean Journal of Cancer, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Toward the Development of a Universal Grading System for Ovarian Epithelial Carcinoma: I. Prognostic Significance of Histopathologic Features—Problems Involved in the Architectural Grading SystemGynecologic Oncology, 1998
- Recent Advances in Chemoprevention of CancerScience, 1997
- Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient MiceCell, 1997
- Apoptotic Index in Ovarian Carcinoma: Correlation with Clinicopathologic Factors and PrognosisGynecologic Oncology, 1997
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995
- Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulcerationCell, 1995
- Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IINature, 1995